
Biogen Inc (NASDAQ:BIIB) is trading lower Thursday morning after the company announced worse-than-expected fourth-quarter earnings results and issued guidance below estimates.
Biogen reported quarterly revenue of $2.73 billion, which beat the estimate of $2.62 billion. The company reported adjusted earnings of $3.39 per share, which came in below the $3.40 estimate.